新型II型糖尿病治疗药物——二肽基肽酶IV抑制剂研究进展

摘要

Type 2 diabetes mellitus is one of the most common chronic disease that seriously threaten modem human health. As a new class of type 2 diabetes mellitus treat agents, dipeptidyl peptidase IV (DPP-IV) inhibitors have attracted more attention in recent years. In the paper, we introduced the pharmacological effects and mechanisms of DPP-IV inhibitors and research progress.%2型糖尿病是一种常见慢性病，严重威胁人类健康，现有药物已无法有效阻止2型糖尿病患者病情的恶化。二肽基肽酶IV（DPP—IV）抑制剂作为一种治疗2型糖尿病的新型药物引起了越来越多的关注。文章介绍了DPP-IV抑制剂药理学作用机制及研究进展。